Compare BioNTech SE - ADR (BNTX) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Under Armour Inc Class A — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Under Armour Inc Class A trades at $5.24 (market cap $2.26B). The key difference: BioNTech SE - ADR is far larger — about 10.3× Under Armour Inc Class A's market cap. Which is the better fit depends on your goals.
| BNTX | UA | |
|---|---|---|
Market Cap | $23.31B | $2.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $7.88 |
52-Week Low | $83.89 | $3.96 |
Enterprise Value | $6.60B | $3.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
